A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis
Status:
Recruiting
Trial end date:
2023-08-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of mirikizumab as
maintenance therapy in participants who completed prior 12-week induction study AMAN
(NCT03518086).